Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study.

Trial Profile

Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2016

At a glance

  • Drugs Carboplatin (Primary) ; Ixabepilone (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms ECLIPSE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Dec 2011 A poster on this trial will be presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, according to a McKesson Specialty Health media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top